Rosetta Genomics Ltd News (NASDAQ:ROSG)
| Latest Rosetta Genomics Ltd News Headlines | | Date | Time | Source | | | 07/09/2008 | 8:30AM | PRNUS | Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in
Study Demonstrates Differentiation of Primary Tumors From Metastases in the Brain With Accuracy Near 90%
REHOVOT, Israel and JERSEY CITY, New Jersey, July 9
/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the development of microRNA-based diagnostic and therapeutic products, announced today... More...>> |
| 07/03/2008 | 8:30AM | PRNUS | Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference
REHOVOT, Israel and JERSEY CITY, New Jersey, July 3
/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd (NASDAQ:ROSG), a leading developer of microRNA-based diagnostics and therapeutics, announced today it will present Collins Stewart Fourth Annual Growth Conference on Wednesday, July 9, at 8:30 am EST at the Mandarin Oriental... More...>> |
| 06/25/2008 | 4:45PM | PRNUS | Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer
REHOVOT, Israel and JERSEY CITY, New Jersey, June 25
/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDAQ:ROSG), announced today that Tamir Kazaz, the Company's CFO for the last two and a half years, has resigned to pursue other interests. The Company has begun a search for a new Chief Financial Officer. Mr. Kazaz... More...>> |
| 06/25/2008 | 8:30AM | PRNUS | Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
Collaboration to Focus on the Development of MicroRNA-Based Tests for Oncology and Women's Health Indications
REHOVOT, Israel and JERSEY CITY, New Jersey, June 25
/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDAQ:ROSG), announced today a collaboration with the Rabin Medical Center in Israel to develop microRNA-based... More...>> |
| 06/18/2008 | 8:30AM | PRNUS | Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
New Development Programs to Include Response Prediction to Ovarian Cancer Treatment, Predicting Risk of Gastric Cancer Recurrence, and Differentiation of Small Cell From Non-Small Cell Lung Cancer
REHOVOT, Israel and JERSEY CITY, New Jersey, June 18
/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd. (NASDAQ:ROSG), a leader... More...>> |
| 06/11/2008 | 8:30AM | PRNUS | Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Test
Rosetta Genomics has Signed a Binding Term Sheet to Acquire Parkway Clinical Laboratories Inc., a Company Owning a Clinical Laboratory Improvement Act (CLIA) Certified Lab
REHOVOT, Israel and JERSEY CITY, New Jersey, June 11
/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd. (NASDAQ:ROSG), a leader in the development... More...>> |
| 06/06/2008 | 8:30AM | PRNUS | Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
Collaboration Will Seek to Identify Unique microRNA Signatures That Will Predict Risk of Recurrence in Lung Cancer Patients
REHOVOT, Israel and JERSEY CITY, New Jersey, June 6
/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the development of microRNA-based diagnostic and therapeutic products... More...>> |
| 05/21/2008 | 10:28AM | PRNUS | /C O R R E C T I O N -- Rosetta Genomics Ltd/
In the news release, "Rosetta Genomics Reports First Quarter 2008 Financial Results" issued on 21 May 2008 12:30 GMT, by Rosetta Genomics Ltd nasdaq:ROSG over PR Newswire, we are advised by a representative of the company that the time of the conference call, as stated beneath the header 'Conference Call Information', should... More...>> |
| 05/21/2008 | 8:30AM | PRNUS | Rosetta Genomics Reports First Quarter 2008 Financial Results
First Diagnostic Test Based on Company's microRNA Technology Submitted for Regulatory Approval to the New York State Department of Health by Columbia University Medical Center
REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, May 21
/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDAQ:ROSG), a leading molecular... More...>> |
| 05/16/2008 | 8:30AM | PRNUS | Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
MicroRNAs as Potential Biomarkers -- for Lung Cancer Diagnosis and Identification of Tumor Origin in Patients With Cancer of Unknown Primary (CUP)
REHOVOT, Israel and JERSEY CITY, New Jersey, May 16
/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd. (NASDAQ:ROSG), a leader in the development of microRNA-based diagnostics... More...>> |
| 05/14/2008 | 8:30AM | PRNUS | Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results
REHOVOT, Israel and JERSEY CITY, New Jersey, May 14
/PRNewswire-FirstCall/ -- Rosetta Genomics (NASDAQ:ROSG), today announced it will release first quarter financial results on May 21, 2008, before the U.S. markets open. Rosetta Genomics will host a conference call with a simultaneous webcast to discuss these results... More...>> |
| 04/28/2008 | 8:30AM | PRNUS | Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
Rosetta Genomics In-Licenses, on a Non-Exclusive Basis, Proprietary MicroRNAs for Research Applications From Rockefeller University
REHOVOT, Israel and JERSEY CITY, New Jersey, April 28
/PRNewswire-FirstCall/ -- Rosetta Genomics (NASDAQ:ROSG), a leading developer of microRNA-based diagnostics and therapeutics, announced... More...>> |
| 04/14/2008 | 8:30AM | PRNUS | Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Te
Tests Will be Developed and Validated Clinically at Clinical Laboratory Improvement Amendments (CLIA) Certified Laboratory at the University of California, Irvine School of Medicine
REHOVOT, Israel and JERSEY CITY, New Jersey, April 14
/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDAQ:ROSG), a leader in the development... More...>> |
| 04/11/2008 | 8:30AM | PRNUS | Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference
REHOVOT, Israel and JERSEY CITY, New Jersey, April 11
/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd. (NASDAQ:ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, announced today it will present multiple posters at the upcoming annual AACR conference in San Diego. The posters will include... More...>> |
| 04/03/2008 | 8:30AM | PRNUS | Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic
The Laboratory-Developed Test is Designed to Differentiate Squamous From Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Classifying Squamous Cell Carcinoma of the Lung With Sensitivity of 96 Percent and Specificity of 90 Percent.
REHOVOT, Israe and JERSEY CITY, New Jersey and NEW YORK, April 3
/PRNewswire-FirstCall/... More...>> |
| 03/25/2008 | 7:00AM | PRNUS | Featured Stocks on Today's Edition of WallSt.net's 3-Minute Press Show: STHG, ROSG
NEW YORK, March 25 /PRNewswire/ -- WallSt.net's 3-Minute Press Show is a daily video program hosted by WallSt.net reporter, Tracee Tolentino.
Shows air Monday through Friday on: http://www.wallst.net/wallst_tv/3_minute_press_show/index_wallst.php.
WallSt.net's 3-Minute Press Show features in-depth interviews with... More...>> |
| 03/24/2008 | 8:30AM | PRNUS | Accurate Identification of Tumor Origin Using MicroRNAs is Published by Rosetta Genomics' Scientists and Collaborators in Nature
A Published Study Shows the Potential of microRNAs to be Used as Biomarkers for Diagnosing the Primary Tumor Site in Patients With Cancer of Unknown Primary (CUP)
REHOVOT, Israel and JERSEY CITY, New Jersey, March 24
/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDAQ:ROSG), announced today that the results of... More...>> |
| 03/03/2008 | 8:30AM | PRNUS | Rosetta Genomics Announces Allowance of Two Additional microRNA Patents
Allowances Further Strengthen Company's Leading microRNA Intellectual Property Position
REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, March 3
/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG) announced today that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for two of... More...>> |
| 02/29/2008 | 8:00AM | PRNUS | Rosetta Genomics Reports Fourth-Quarter and Full-Year 2007 Financial Results
Launch of First Three Diagnostic Tests Based on Company's microRNA Technology on Schedule for 2008
REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, February 29
/PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDAQ:ROSG), a leading molecular diagnostics company, today reported a narrower operating loss per ordinary... More...>> |
| 02/21/2008 | 8:30AM | PRNUS | Rosetta Genomics Announces Conference Call and Webcast of Fourth Quarter Financial Results
REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, February 21
/PRNewswire-FirstCall/ -- Rosetta Genomics (NASDAQ:ROSG), today announced it will release fourth quarter financial results on February 29, 2007, before the U.S. markets open. Rosetta Genomics will host a conference call with a simultaneous webcast to discuss... More...>> |
|
|
|